Building an ACE2 Receptor Trap for Pandemic Pathogens
Researchers led by the University of California, San Francisco and the University of Alberta, Edmonton have engineered angiotensin-converting enzyme II ...
Researchers led by the University of California, San Francisco and the University of Alberta, Edmonton have engineered angiotensin-converting enzyme II ...
More than 8 million people in the United States have now tested positive for COVID-19. For those who’ve recovered, many ...
In recovering COVID-19 patients, antibodies fade quickly, but adequate time must be given to clear viral particles before plasma collection ...
Researchers from the U.S. Army Futures Command, in collaboration with Houston Methodist, Pennsylvania State University, and UT Austin, tested alternative ...
The National Institutes of Health (NIH) today announced it is expanding enrollment in two existing clinical trials to further evaluate ...
In collaboration with UT Austin, Penn State University and the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), study ...
A team of Johns Hopkins experts has created a clinical guidebook to help hospitals and medical centers rapidly scale up ...
The U.S. Department of Health and Human Services (HHS) will collaborate with multiple non-government organizations on the development of convalescent ...
Amgen and Adaptive Biotechnologies announced a collaboration aimed at combing expertise to discover and develop fully human neutralizing antibodies targeting ...
Emergent BioSolutions Inc. announced today that it has entered into a formal partnership with the U.S. government to expedite development of a ...
With no drugs or vaccines yet approved for COVID-19 and the number of U.S. cases increasing by the thousands every ...
The FDA is facilitating access to convalescent plasma, antibody-rich blood products that are taken from blood donated by people who ...
We currently lack serological assays suitable to specifically detect SARS-CoV-2 antibodies, of critical importance to determine seroprevalence in a given ...
Countries fighting outbreaks of the novel coronavirus disease COVID-19 should consider using the antibodies of people who have recovered from ...